John Philip
Titel
Citeras av
Citeras av
År
Differential exoprotease activities confer tumor-specific serum peptidome patterns
J Villanueva, DR Shaffer, J Philip, CA Chaparro, H Erdjument-Bromage, ...
The Journal of clinical investigation 116 (1), 271-284, 2006
8822006
Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry
J Villanueva, J Philip, D Entenberg, CA Chaparro, MK Tanwar, ...
Analytical chemistry 76 (6), 1560-1570, 2004
5922004
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
5912020
Correcting common errors in identifying cancer-specific serum peptide signatures
J Villanueva, J Philip, CA Chaparro, Y Li, R Toledo-Crow, L DeNoyer, ...
Journal of proteome research 4 (4), 1060-1072, 2005
2552005
Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age
J Villanueva, AJ Martorella, K Lawlor, J Philip, M Fleisher, RJ Robbins, ...
Molecular & Cellular Proteomics 5 (10), 1840-1852, 2006
1982006
Isolation and mass spectrometry of transcription factor complexes
GS Winkler, L Lacomis, J Philip, H Erdjument-Bromage, JQ Svejstrup, ...
Methods 26 (3), 260-269, 2002
922002
InJection adaptable Fine Ionization Source (‘JaFIS’) for continuous flow nano‐electrospray
S Geromanos, J Philip, G Freckleton, P Tempst
Rapid communications in mass spectrometry 12 (9), 551-556, 1998
511998
Data analysis of assorted serum peptidome profiles
J Villanueva, J Philip, L DeNoyer, P Tempst
Nature protocols 2 (3), 588, 2007
432007
Chemotherapy and COVID-19 outcomes in patients with cancer
J Jee, MB Foote, M Lumish, AJ Stonestrom, B Wills, V Narendra, V Avutu, ...
Journal of Clinical Oncology 38 (30), 3538-3546, 2020
422020
Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer
A Nazarian, K Lawlor, J Philip, M Ghosh, M Yaneva, J Villanueva, ...
Molecular & Cellular Proteomics 13 (11), 3082-3096, 2014
342014
Deep coverage of global protein expression and phosphorylation in breast tumor cell lines using TMT 10-plex isobaric labeling
FK Huang, G Zhang, K Lawlor, A Nazarian, J Philip, P Tempst, ...
Journal of proteome research 16 (3), 1121-1132, 2017
332017
Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
P Mondello, E Derenzini, Z Asgari, J Philip, EJ Brea, V Seshan, ...
Oncotarget 8 (8), 14017, 2017
322017
Validation of a digital pathology system including remote review during the COVID-19 pandemic
MG Hanna, VE Reuter, O Ardon, D Kim, SJ Sirintrapun, PJ Schüffler, ...
Modern Pathology 33 (11), 2115-2127, 2020
242020
Prognostic molecular subtypes of low-grade cancer of the appendix
EA Levine, KI Votanopoulos, SA Qasem, J Philip, KA Cummins, JW Chou, ...
Journal of the American College of Surgeons 222 (4), 493-503, 2016
242016
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
KL Bolton, RN Ptashkin, T Gao, L Braunstein, SM Devlin, D Kelly, M Patel, ...
Nature genetics 52 (11), 1219-1226, 2020
212020
Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study
G Tang, JKSS Philip, O Weinberg, W Tam, S Sadigh, JI Lake, ...
Modern Pathology 32 (4), 490-498, 2019
192019
Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia
NA McNeer, J Philip, H Geiger, RE Ries, VP Lavallee, M Walsh, M Shah, ...
Leukemia 33 (8), 1934-1943, 2019
172019
HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons
S Kishinevsky, T Wang, A Rodina, SY Chung, C Xu, J Philip, T Taldone, ...
Nature communications 9 (1), 1-15, 2018
162018
BET inhibition-induced GSK3β feedback enhances lymphoma vulnerability to PI3K inhibitors
E Derenzini, P Mondello, T Erazo, A Portelinha, Y Liu, M Scallion, ...
Cell reports 24 (8), 2155-2166, 2018
162018
Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer
WG Qiu, A Polotskaia, G Xiao, L Di, Y Zhao, W Hu, J Philip, ...
NPJ breast cancer 3 (1), 1-9, 2017
142017
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20